Anti-ngf antibodies and methods using same
CA 2936742 C · Owner: Rinat Neuroscience Corp. · Inventors: Rosenthal, Arnon; Shelton, David L.; Pons, Jaume
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies) and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain including post-surgical pain, rheumatoid arthritis pain and osteoarthritis pain.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 24, 2003 and granted May 26, 2020. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 24, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 24, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.